Navidea Biopharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
NAVB on OTC
Location
4995 Bradenton Avenue, Suite 240, Dublin, OH

There are no Buy or Sell transactions made by insiders since 11/23/2023

Navidea Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John K. Scott Jr. Director, 10%+ Owner $2.8M Nov 27, 2023
Craig Dais Chief Financial Officer $85.7K Nov 10, 2023
Jill Stefanelli Director $82.9K Nov 16, 2023
Dana J. Moss Director $76.3K Nov 16, 2023
Malcolm G. Witter Director $14.5K Nov 30, 2022
Amit Bhalla Director $6.32K Nov 30, 2022
L. Cappello Director $5.96K Nov 30, 2022
Michael S. Rosol Chief Medical Officer $5.9K Sep 9, 2022
Agnieszka Winkler Director $2.96K Nov 15, 2021
Thomas F. Farb Director $2.94K Nov 15, 2021
Joshua M. Wilson Director $2.64K Nov 29, 2022
Sarah Kathryn Rouan Director $1.61K Jun 30, 2021
Claudine Bruck Director $1.45K Jun 30, 2021
Michel Mikhail Chief Regulatory Officer Nov 15, 2021

Recent Insider Transactions by Companies or Individuals for Navidea Biopharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.